Primary Pulmonary Hypertension Presented by The Law Offices of Nadrich & AssociatesThe common use of Fen-Phen diet drugs Redux and Pondimin have led to an unprecidented number of new Primary Pulmonary Hypertension (PPH) cases over the last 10 years. The FDA removed these popular diet drugs from the marketplace in 1997 because of links to Primary Pulmonary Hypertension and other heart conditions such as mitral and aortic valve regurgitation.

If you have taken Redux or Pondimin and have experienced any of the following medical conditions, you should seek medical attention immediately.

Symptoms of Primary Pulmonary Hypertension

  • Progressive shortness of breath with activity
     
  • Hyperventilation
     
  • Chest pain under the sternum
     
  • Weakness
     
  • Fatigue
     
  • Fainting
     
  • Lightheadedness with upright posture
     
  • Dizziness
     
  • Coughing up blood

Pulmonary hypertension develops as a response to increased resistance to blood flow. Diffuse narrowing of the pulmonary arterioles occurs. The right side of the heart becomes enlarged due to the increased work load of pumping blood against this resistance. Eventually, progressive heart failure develops.

Historically, people at risk of developing Primary Pulmonary Hypertension were women between 20 and 40 years old, although the disease can affect any sex and age. The incidence is 8 out of 100,000 people. It is rare in children. More common is pulmonary hypertension in infants with persistent fetal circulation.

The Law Offices of Nadrich & Associates is a fifteen person law firm which does commit the necessary resources to fight any pharmaceutical corporation including the manufacturers of Redux and Pondimen and all other diet drugs. We work on a contingency fee basis. A contingency fee means we only obtain a fee if we make a recovery.  If we do not win the case or make a recovery our clients owe us nothing for our time, costs or expenses.  

With many decades of combined experience, the Law Offices of Nadrich & Associates,  and our highly experienced staff of trial attorneys, paralegals, investigators and law clerks have the expertise and ample resources to successfully research, investigate and litigate all of our clients Primary Pulmonary Hypertension claims. We promise every client that their claim will be reviewed diligently and carefully. If we take a case, we will work extremely hard to obtain the best possible result.  We can help you immediately.  All e-mail and form submissions will be responded to by a qualified member of our firm within 24 hours.

Original Content is Copyright �2002 Nadrich & Associates, Inc. All Rights Reserved.

Disclaimer: The Phen Fen, Fen Phen, PPH, Phen Fen settlement, Phen Fen lawsuit, Phen Fen class actions, Fen Phen litigation, FenPhen side effects, dangerous drugs, drug error, personal injury, negligence, medical malpractice, wrongful death or other legal information presented at this site should not be construed to be formal legal advice, nor the formation of a lawyer or attorney client relationship. This web site and the information contained herein are for informational purposes only and not for legal advice. This web site is for providing general helpful information to members of the public in need of a licensed Phen Fen attorney.